NMTC · CIK 0001500198 · FY2025 live · 2025-09-30
NEUROONE MEDICAL TECHNOLOGIES Corp
View as
Model
Classic Z
FY2025
−8.63
Zone
Distress
Prior
—
Market DD
—
1y PD
—
Meridian Rank
15.18
0–100 · Classic Z tape · not a PD
Book standing
10
Year change
—
Market PD
—
O-score
29
Events on this name
Same published rows as Today. Not a live recompute.
Market PD unavailable
watch · 41
−8.63
Z″ −19.57
Score −8.63 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.731.2 × = 0.88X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−7.291.4 × = −10.20X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.393.3 × = −1.29X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
1.900.6 × = 1.14X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.841 × = 0.84
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
NEUROONE MEDICAL TECHNOLOGIES Corp is on classic Z at −8.63 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 18th percentile in Healthcare.
- KPRXDistressKIORA PHARMACEUTICALS INC−8.56
- CMPSDistressCOMPASS Pathways plc−8.73
- SLGLDistressSol-Gel Technologies Ltd.−8.51
- HCWBDistressHCW Biologics Inc.−8.81
- RMTIDistressROCKWELL MEDICAL, INC.−8.44
- ONCODistressOnconetix, Inc.−8.82
- VRCADistressVerrica Pharmaceuticals Inc.−8.42
- ACRSDistressAclaris Therapeutics, Inc.−8.38
KPI widgets
Current assets
$10M
Total assets
$11M
Current liabilities
$2M
Total liabilities
$4M
Working capital
$8M
Retained earnings
−$79M
EBIT
−$4M
Total sales
$9M
Book equity
$7M
Accession 0001213900-25-122390. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-09-30). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.